Tryptamine Therapeutics (AU:TYP) has released an update.
Tryptamine Therapeutics Inc. has amended its interim consolidated financial statements for the six-month period ending February 29, 2024. Key financial documents such as statements of financial position, comprehensive loss, shareholders’ equity, and cash flows have been updated. This could indicate significant changes in the company’s financial health, which may interest investors.
For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.
